Gemini Pharmaceuticals Nigeria Limited has positioned herself as a quality oriented Company since 1972. This Company goes the extra mile to ensure that its products have the best in class quality, so as to maintain its heritage of quality, trust and efficacy which the Medical Community and patients alike have come to associate Gemini and its product brands with.
The Company's Products ranges are Vecuten Cream, Sabresten Cream, Gemini Paracetamol, Nifegem Retard, Microgem Cream, Metrogem, Ciprogem Tablets, Multiseng, Cotrigem, Mitigem and Sabresten Vaginal Cream.
Gemini Pharmaceuticals Nigeria Limited was incorporated in 1972 by Bayer A.G. Leverkusen, and Dr. M. B. Unuane with sole objective to market and manufacture Bayer AG's Pharmaceutical Specialties in Nigeria. At the inception, 60% of its shares was owned by Bayer AG Leverkusen, West Germany and 40% by Nigerians.
In 1974, a Joint Venture agreement was signed between Dr. M. B. Unuane, Dr. T. A. Odutola and Bayer AG, Leverkusen. The name was changed to Bayer Pharmaceuticals Nigeria Limited. The then company acquired 12 acres of land at Apapa / Oshodi Express Amuwo-Odofin, Lagos for the purpose of erecting Pharmaceutical Manufacturing Company. The ultra modern factory was commissioned in 1982. Commercial activities also commenced the same year.
In the late 80’s, Bayer A.G., as part of its global policy decided to disengage from its activities in the third world countries to allow indigenes to own and manage their subsidiary companies. The share of Bayer AG and Dr.T. A. Odutola was acquired by DR. M. B. UNUANE and the company was formally handed to him on 30th June 1993. It reversed to its original name "Gemini Pharmaceutical Nigeria Limited". With a Franchise and Licence Agreement, to continue to manufacture Bayer AG Pharmaceutical Specialist in Nigeria until 2002.
To be the foremost Manufacturer of High Quality, Trusted and Affordable Pharmaceutical Products.
Gemini Pharmaceuticals (Nig.) Ltd seeks to excel in the provision of effective and dynamic healthcare delivery through the manufacturing of high quality pharmaceutical products, education, medical services and research.